Featured Entrepreneurs

Since 2010, MassChallenge has accelerated 1,975 startups that have raised more than $4.3 billion in funding, generated more than $2.5 billion in revenue, and created more than 121,000 total jobs. 

Our startups

Be inspired. Search our startups.

Clear  
Akanocure Pharmaceuticals, Inc.

Akanocure is developing a group of novel bio-inspired anti-cancer next generation small molecules (SGSM) that would have the affinities and elicit the protein-protein interaction modulation of macromolecules while retaining the high tumor permeability of small molecules. SGSM are designed to be inexpensive to develop, avoid the side effects of chemotherapy, elicit response in most patients, suppress metastasis and relapse, and could be synergistic when combined with immunotherapies.
Our mission is to introduce second generation small molecules (SGSM) as breakthrough therapeutics for orphan and unmet needs in cancer.

Connect with Akanocure Pharmaceuticals, Inc.

Akanocure Pharmaceuticals, Inc.

2017

Sub industry

Therapeutics (Pharma / Biotech)

Additional Industries
Marine Technology

Mission

MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.